Two New Parkinson’s Therapies Enter Final Stages of Clinical Trials

Posted on by Rebecca Gilbert, MD, Ph.D.

New treatments on the Horizon for Parkinson’s Two new therapies are entering the final stages of clinical trials before...see more potential FDA approval. One is a novel dopamine-based therapy for motor symptom management, and the other is a stem cell therapy poised to replace the lost brain cells of Parkinson’s disease (PD). Together, they represent two […]

Read More

Parkinson’s Disease and the Gut: Additional Questions Answered

Posted on by Rebecca Gilbert, MD, Ph.D.

On a recent episode of APDA’s Dr. Gilbert Hosts, Dr. Gilbert spoke with Dr. Malu Gamez Tansey, the James A....see more Caplin, MD Chair in Alzheimer’s Disease at Indiana University School of Medicine and Director of Neuroimmunology Research Group, with expertise in the relationship between gut inflammation and Parkinson’s disease (PD). We covered a lot of ground […]

Read More

Parkinson’s Advocacy: A Conversation with Anne Hubbard, APDA’s Chief Public Policy Officer

Posted on by Rebecca Gilbert, MD, Ph.D.

In August 2025, the American Parkinson Disease Association (APDA) welcomed Anne Hubbard as its first-ever Chief Public Policy Officer,...see more marking a major step forward in strengthening the organization’s voice in public policy and advocacy. Anne now leads APDA’s newly created Department of Public Policy & Advocacy, where she is developing a comprehensive strategy to promote […]

Read More

Parkinson’s Disease Advocacy at APDA

Posted on by Rebecca Gilbert, MD, Ph.D.

We’re at a Turning Point for Parkinson’s — Your Story Can Help Move Congress The Parkinson’s disease (PD) community...see more is currently facing both urgent challenges and real opportunities. More than 90,000 Americans are diagnosed each year, and over 1 million people are living with Parkinson’s nationwide. At the same time, new legislation, scientific progress, and […]

Read More

APDA’s New Bridge Funding Awardees for Parkinson’s Research

Posted on by Rebecca Gilbert, MD, Ph.D.

Announcing Bridge Funding to Alleviate Parkinson’s Research Funding Cuts The American Parkinson Disease Association (APDA) funds cutting-edge research every...see more year, identifying the most promising researchers and projects through a meticulous evaluation process. APDA has recently gone a step further to ensure that researchers who are facing unexpected delays and even cuts in funding have a […]

Read More

Understanding Young Onset Parkinson’s Disease

Posted on by Rebecca Gilbert, MD, Ph.D.

What is Young Onset Parkinson’s Disease? When Parkinson’s disease (PD) is diagnosed between the ages of 21 and 50,...see more it is called young onset, or early onset Parkinson’s disease (YOPD). Though symptoms overlap with typical PD, younger people face unique challenges, and even some surprising advantages, in managing the disease.   Who Gets Young Onset […]

Read More

Tips for Traveling with Parkinson’s Disease

Posted on by Rebecca Gilbert, MD, Ph.D.

People travel for many reasons – to see family, for business purposes, to...see more explore new sites or just to relax and unwind. Traveling often brings unexpected challenges, especially for those with Parkinson’s disease (PD). However, with proper and proactive planning, there is no need to let PD hold you […]

Read More

Making Hope Possible: APDA Supports Researchers with $4.04 Million in New Funding

Posted on by Rebecca Gilbert, MD, Ph.D.

Supporting Innovative Scientists and Breakthrough Discoveries The American Parkinson Disease Association (APDA) proudly announces $4.04 million in new funding...see more for cutting-edge Parkinson’s disease (PD) research – representing a 55% increase in research funding from the previous year. These new awards support a remarkable group of scientists, each dedicated to advancing our understanding of PD and […]

Read More

Brain Imaging for Parkinson’s Disease

Posted on by Rebecca Gilbert, MD, Ph.D.

Parkinson’s disease (PD) is typically diagnosed based on clinical exam, but there are imaging tests that are available to...see more help in diagnosis. The most commonly known in the US is the Dopamine Transporter Scan (DaTscan), an imaging test in which a radioactive tracer, Ioflupane (123I) — which is also called DaTscan — is injected into the […]

Read More